Aura Biosciences Stock Investor Sentiment

AURA Stock  USD 7.49  0.12  1.63%   
About 63% of all Aura Biosciences' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Aura Biosciences suggests that some traders are interested. The current market sentiment, together with Aura Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Aura Biosciences stock news signals to limit their universe of possible portfolio assets.
  

Aura Biosciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Aura Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
3 days ago at finance.yahoo.com         
Aura Unites with Boston Childrens Hospital to Address the Role of Technology in the Crisis of Wellbe...
Yahoo News
over a week ago at thelincolnianonline.com         
Aura Biosciences, Inc. SVP Sells 10,881.00 in Stock
news
over a week ago at www.macroaxis.com         
Disposition of 20221 shares by De Los Pinos Elisabet of Aura Biosciences at 7.7541 subject to Rule 1...
Macroaxis News
over two weeks ago at newswire.com         
Clear Capitals Appraisal Underwriting Risk Analyzer, AURA, now Available Through ICE Mortgage Techno...
news
over two weeks ago at finance.yahoo.com         
Clear Capitals Appraisal Underwriting Risk Analyzer, AURA, now Available Through ICE Mortgage Techno...
Yahoo News
over two weeks ago at finance.yahoo.com         
Companies Like Aura Biosciences Are In A Position To Invest In Growth
Yahoo News
over two weeks ago at thelincolnianonline.com         
Q1 Earnings Forecast for AURA Issued By Leerink Partnrs
news
over three weeks ago at news.google.com         
How to Take Advantage of moves in - Stock Traders Daily
Google News at Macroaxis
over three weeks ago at www.macroaxis.com         
Acquisition by Amy Elazzouzi of 29760 shares of Aura Biosciences at 7.68 subject to Rule 16b-3
Macroaxis News
over three weeks ago at thelincolnianonline.com         
Aura Biosciences, Inc. Short Interest Update
news
over a month ago at www.macroaxis.com         
Acquisition by Mattessich Antony C. of 10500 shares of Aura Biosciences subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
Regency Capital Management Inc. DE Sells 57,887 Shares of Aura Biosciences, Inc. - MarketBeat
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
FY2024 Earnings Forecast for AURA Issued By Lifesci Capital
news
over a month ago at simplywall.st         
This Insider Has Just Sold Shares In Aura Biosciences
Simply Wall St News at Macroaxis
over a month ago at thelincolnianonline.com         
Los Pinos Elisabet De Sells 15,955 Shares of Aura Biosciences, Inc. Stock
news
Far too much social signal, news, headlines, and media speculation about Aura Biosciences that are available to investors today. That information is available publicly through Aura media outlets and privately through word of mouth or via Aura internal channels. However, regardless of the origin, that massive amount of Aura data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aura Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aura Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aura Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aura Biosciences alpha.

Aura Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Aura Announces Bluestone Securityholders Approval of Transaction
12/19/2024
2
Long Focus Capital Management, LLC Increases Stake in Aura Biosc - GuruFocus.com
01/03/2025
3
Baylor Genetics to Integrate with Epic Aura to Enhance Efficiency and Deliver Genetic Testing Results to Hospitals and Health Systems
01/13/2025
4
Disposition of 1001 shares by Amy Elazzouzi of Aura Biosciences at 7.6715 subject to Rule 16b-3
01/21/2025
5
This Insider Has Just Sold Shares In Aura Biosciences
01/24/2025
6
Acquisition by Mattessich Antony C. of 10500 shares of Aura Biosciences subject to Rule 16b-3
01/27/2025
7
Aura Biosciences, Inc. Short Interest Update
01/31/2025
8
Acquisition by Amy Elazzouzi of 29760 shares of Aura Biosciences at 7.68 subject to Rule 16b-3
02/03/2025
9
Q1 Earnings Forecast for AURA Issued By Leerink Partnrs
02/07/2025
10
Clear Capitals Appraisal Underwriting Risk Analyzer, AURA, now Available Through ICE Mortgage Technologys Encompass Platform
02/13/2025
11
Disposition of 20221 shares by De Los Pinos Elisabet of Aura Biosciences at 7.7541 subject to Rule 16b-3
02/18/2025
12
Aura Unites with Boston Childrens Hospital to Address the Role of Technology in the Crisis of Wellbeing Among American Children
02/26/2025

Complementary Tools for Aura Stock analysis

When running Aura Biosciences' price analysis, check to measure Aura Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aura Biosciences is operating at the current time. Most of Aura Biosciences' value examination focuses on studying past and present price action to predict the probability of Aura Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aura Biosciences' price. Additionally, you may evaluate how the addition of Aura Biosciences to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stocks Directory
Find actively traded stocks across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges